Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;40(1):258-264.
doi: 10.1111/jgh.16787. Epub 2024 Nov 20.

Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type

Aryoung Kim  1   2 , Danbee Kang  3   4 , Sung Chul Choi  5 , Dong Hyun Sinn  1 , Geum-Youn Gwak  1
Affiliations

Cardiometabolic risk factors and coronary atherosclerosis progression in patients with metabolic dysfunction-associated steatotic liver disease: the influential role of quantity over type

Aryoung Kim et al. J Gastroenterol Hepatol. 2025 Jan.

Abstract

Background and aim: Individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at an increased risk of cardiovascular disease (CVD) are critical to identify and manage. We aimed to assess whether the risk of CVD in patients with MASLD differed according to the type or number of cardiometabolic risk factors.

Methods: This longitudinal cohort study involved 5674 adults who underwent at least two health checkups between 2004 and 2021. Steatotic liver disease (SLD) was assessed using ultrasonography and participants with SLD were classified as having either non-MASLD or MASLD. CVD risk was evaluated using coronary artery calcium (CAC) progression as measured using multidetector computed tomography scans.

Results: Over an average 5.8-year follow-up period, patients with MASLD exhibited faster CAC progression than those with non-MASLD (18% vs 11%, P < 0.01). MASLD with any cardiometabolic risk factor exacerbated CAC progression; however, the degree of CAC progression was similar among the different risk components. The adjusted ratios (95% CI) of CAC progression rates comparing non-MASLD with MASLD with one, two, three, four, and five cardiometabolic risk factors were 1.02 (0.99, 1.06), 1.04 (1.01, 1.08), 1.07 (1.03, 1.10), 1.08 (1.05, 1.11), and 1.11 (1.07, 1.15), respectively.

Conclusions: In individuals with MASLD, all cardiometabolic risk factors contributed to the deterioration of coronary atherosclerosis, with no specific factor exerting a dominant influence. Coronary atherosclerosis progression is directly associated with the cumulative number of cardiometabolic risk factors. Therefore, identifying and managing an increasing number of these factors is imperative in clinical practice, even when MASLD is diagnosed based on only one risk factor.

Keywords: cardiometabolic risk factors; coronary artery calcium progression; metabolic dysfunction‐associated steatotic liver disease (MASLD).

PubMed Disclaimer

References

    1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 1980; 55: 434–438.
    1. Eslam M, Sanyal AJ, George J et al. MAFLD: a consensus‐driven proposed nomenclature for metabolic associated fatty Liver disease. Gastroenterology 2020; 158: 1999–2014.e1.
    1. Rinella ME, Lazarus JV, Ratziu V et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 2023; 78: 1966–1986.
    1. Del Ben M, Baratta F, Polimeni L, Angelico F. Non‐alcoholic fatty liver disease and cardiovascular disease: epidemiological, clinical and pathophysiological evidences. Intern. Emerg. Med. 2012; 7: S291–S296.
    1. Xiao J, Ng CH, Chan KE et al. Hepatic, extra‐hepatic outcomes and causes of mortality in NAFLD ‐ an umbrella overview of systematic review of meta‐analysis. J. Clin. Exp. Hepatol. 2023; 13: 656–665.

LinkOut - more resources